Tesamorelin
Stabilized GHRH analog studied for selective visceral adipose tissue effects.
This product is not a drug, food, or cosmetic and is not intended to diagnose, treat, cure, or prevent any disease. Not for human or veterinary use. By purchasing, you confirm you are a qualified researcher or institution acquiring this product solely for in-vitro laboratory research. See our Research Disclaimer for full terms.
Description
Tesamorelin is a 44-amino acid synthetic analog of growth hormone-releasing hormone (GHRH), stabilized with an N-terminal modification for enhanced resistance to enzymatic degradation. It binds GHRH receptors on pituitary somatotrophs, stimulating pulsatile endogenous growth hormone release while preserving natural somatostatin feedback — distinct from direct GH administration. Phase 3 clinical research demonstrated selective reductions in visceral adipose tissue of roughly 15-18% over 26 weeks, and it remains an active research compound in studies of hepatic lipid metabolism and GH-axis signaling. Supplied for in-vitro laboratory research only — not for human or veterinary use.